Article Text

Download PDFPDF

Right heart transiting thrombi caused by endovenous sclerotherapy: the treatment is not consensual
  1. Driss Laghlam1,
  2. Sara Hamadouche1,
  3. Raphael Dautry2,
  4. Vincent Spagnoli1
  1. 1Department of Cardiology, Assistance Publique—Hopitaux de Paris, Paris, Île-de-France, France
  2. 2Department of Radiology, Assistance Publique—Hopitaux de Paris, Paris, Île-de-France, France
  1. Correspondence to Dr Vincent Spagnoli, vincent.spagnoli{at}

Statistics from


A 69-year-old woman without medical history, was admitted in our emergency department for acute respiratory distress. Two weeks prior to admission, she had undergone an endovenous foam sclerotherapy of a right saphenous branch with aetoxisclerol 2%. Afterwards, she complained of progressive dyspnoea and right thoracic pain. On arrival at the emergency department, the patient was noted to have cyanosis, a respiratory rate of 35 breaths/min and oxygen saturation of 90% despite high-flow face mask oxygen administration. Heart rate was 115 beats/min and blood pressure was 140/65 mm Hg. On physical examination, superficial thrombosis of a right saphenous branch was noted (figure 1). Laboratory studies demonstrated an elevation of markers of myocardial injuries and right ventricular dysfunction with a troponin I level of 1968 ng/L (reference value <16 ng/L) and brain natriuretic protein level of 541 ng/L (reference value <100 ng/L). Arterial blood …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.